EON NETWORK - ENICTO

Welcome to the Exercise Oncology/Oncology Nutrition (EON) Network!

Our goals:

Support the research needed to develop evidence-based practice guidelines in both exercise oncology and oncology nutrition during cancer treatment
Facilitate communication between the exercise oncology and oncology nutrition communities to achieve the joint goal of improving cancer treatment outcomes
Encourage communication between researchers and clinicians working with people receiving cancer treatment

We are excited to offer this new webinar series and networking opportunity, the Exercise Oncology/Oncology Nutrition (EON) Network, coordinated by the NCI-funded Exercise and Nutrition Interventions to Improve Cancer Treatment-Related Outcomes (ENICTO) Consortium.

News

A monthly EON Network email with information on relevant upcoming events, summaries of recently published research of interest to the exercise oncology and oncology nutrition fields, and relevant research funding opportunities.

Past Newsletters

Webinars

Invitations to the quarterly webinar series on topics of interest to exercise oncology and oncology nutrition researchers and clinicians.

(Continuing education credits are being requested for these webinars, and webinars will be recorded and archived on the EON Network website.)

Webinars

Resources

An EON Resources page with information that is relevant to exercise oncology and oncology nutrition researchers and clinicians.

Resources Page

Fall 2026 Webinar

Wed, October 21st, 3:00 - 4:00 PM ET

Diet and Chemotherapy-Induced Peripheral Neuropathy: Emerging Evidence, Future Directions

Chemotherapy-induced peripheral neuropathy (CIPN) is a significant side effect of certain types of chemotherapies that impacts quality of life and treatment tolerance. Emerging observational evidence has highlighted the relationship between diet and the development and reduction of CIPN. This presentation will discuss this existing body of evidence and the mechanisms by which diet may impact CIPN, particularly CIPN caused by platinum-based chemotherapies. This presentation will also present an upcoming randomized control trial investigating diet to delay CIPN development and explore future directions.

Speaker Background

Stephanie L.E. Compton, Ph.D., RD is a Postdoctoral Research Fellow and Registered Dietitian in the Exercise and Cancer Biology Research Program at AdventHealth Translational Research Institute. Her research examines how nutrition and physical activity impact cancer survivors’ cancer treatment tolerance, chronic disease risk, quality of life, and overall survival. Dr. Compton has received grants from the American Cancer Society, American Institute for Cancer Research, and the National Cancer Institute. She is currently supported by a K99/R00 Pathway to Independence Award from the National Cancer Institute, which is investigating the role of diet in the development of chemotherapy-induced peripheral neuropathy.